Overall, the global intramedullary nail market was valued at $1.1 billion in 2021. This is expected to increase over the forecast period at a CAGR of 4.3% to reach $1.5 billion.

The full report suite on the global market for intramedullary (IM) nails includes humeral, forearm, femoral, tibial and ankle intramedullary nails.

MARKET REPORT DATA TYPES INCLUDED

• Unit Sales, Average Selling Prices, Market Size & Growth Trends
• Procedure Numbers
• COVID-19 Impact Analysis
• Market Drivers & Limiters
• Market Forecasts Until 2028, and Historical Data to 2018
• Recent Mergers & Acquisitions
• Company Profiles and Product Portfolios
• Leading Competitors

PROCEDURE NUMBERS

In 2021, the global intramedullary nail market increased in the number of procedures performed. In 2020, the market saw a decrease in the procedure volume as a result of the COVID-19 pandemic. However, in 2021, the procedure numbers recovered to near pre-pandemic levels. It is expected that the number of procedures performed in this market will grow in the mid-single-digit range over the forecast period.

GLOBAL INTRAMEDULLARY NAIL MARKET TRENDS

Competition in the intramedullary nail market limits its growth potential. Internal competition among competitors has impacted average selling prices negatively, which has moderated market growth. This is furthered by hospitals seeking to reduce the number of vendors, thus intensifying competition.

GLOBAL INTRAMEDULLARY NAIL MARKET SHARE INSIGHTS

Overall, within the global intramedullary nail market there are three dominant competitors: DePuy Synthes, Stryker, and Smith & Nephew.

DePuy Synthes was the leading competitor in the global intramedullary nail market. Although Depuy Synthes was the second-leading competitor in the Western Europe intramedullary nail market, its strong presence in North America and internationally assures its top spot over all competitors in this market.

GLOBAL INTRAMEDULLARY NAIL MARKET SEGMENTATION SUMMARY

• Humeral Intramedullary Nails
• Forearm Intramedullary Nails
• Femoral Intramedullary Nails
• Tibial Intramedullary Nails
• Ankle Intramedullary Nails

Research Scope Summary

WHY CHOOSE iDATA?

• • Experts Only – iData has been around for over 17 years and is the trusted source of intelligence, and data-driven insights for key industry players. We are made up of specialists with a sole focus on medical devices, dental devices and pharmaceuticals. Our research and consulting field of endeavour never strays from the medical device industry and, because of this, we are the number one choice for leading companies in this field.
  • Global Coverage – iData’s unique methodology, and its expansion to over 70 countries world-wide, has made it one of the most viable sources of intelligence for global companies along with those who plan to expand their portfolio beyond the confines of their own country. Providing procedural data at the country level is another testimony to the trusted global coverage we provide.
  • Attention to Detail – It’s our attention to small details, scheduling of timelines, and keen project management that makes us stand out from the rest. We are creative, and our reports include metrics such as procedure numbers, ASPs, and SKU-level insights that are not found elsewhere.
  • Pricing – When comparing like-with-like, iData’s prices are not only extremely competitive but also the most cost-effective. We strive for success and want the same for our clients. With the level of detail incorporated into each report alongside the extensive segmentation provided, no other report compares at our price point.

FREE Sample Report